PAVmed
PAVM
6 hedge funds and large institutions have $141K invested in PAVmed in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
76% less capital invested
Capital invested by funds: $582K → $141K (-$441K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$42.2K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$146K |
| 2 |
Millennium Management
New York
|
-$75.7K |
| 3 |
LCS
Levin Capital Strategies
New York
|
-$60K |
| 4 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$1.76K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $47K | -$75.7K | -43 | -48% |
|
|
MSAM
2
Moloney Securities Asset Management
Manchester,
Missouri
| $33K | -$1.76K | -1 | -3% |
|
|
3
Morgan Stanley
New York
| $25K | +$42.2K | +24 | New |
|
4
Brown Advisory
Baltimore,
Maryland
| $23K | – | – | – |
|
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $11K | +$5.28K | +3 | +38% |
|
6
BlackRock
New York
| $2K | – | – | – |
|
|
7
Goldman Sachs
New York
| – | -$146K | -60 | Closed |
|
|
LCS
8
Levin Capital Strategies
New York
| – | -$60K | -25 | Closed |
|
PAVM Hedge Fund Activity: Q4 2017 in Review
6 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2017, worth a combined $141K — down 76% from $582K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PAVM and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $42.2K. The largest seller was Goldman Sachs, exiting entirely with an estimated $146K sold.
- 6 institutional investors held PAVmed (PAVM) as of Q4 2017, down from 7 in Q3 2017.
- Funds reported $141K of PAVmed stock for Q4 2017, down 76% quarter-over-quarter.
- 1 fund opened new PAVmed positions in Q4 2017 and 2 closed out, a net change of -1 holder.
- The largest PAVmed buyer in Q4 2017 was Morgan Stanley, an estimated $42.2K added.
- The largest PAVmed seller in Q4 2017 was Goldman Sachs, an estimated $146K sold.
Based on aggregated 13F filings for Q4 2017.